Charlotte M. Mosterd
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Mechanisms of SGLT inhibitor action and physiological mediators: systematic review and protocol for the MOSAIC collaborative meta-analysis.
Journal: BMJ open
Published: February 26, 2026
Mechanisms of SGLT inhibitor action and physiological mediators: systematic review and protocol for the MOSAIC collaborative meta-analysis.
Journal: BMJ open
Published: February 26, 2026
Plasma Metabolite N-Formylmethionine Is Associated With Higher Blood Pressure in the Multiethnic HELIUS Cohort and Triggers Vascular Dysfunction.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: September 17, 2025
Plasma and Urine Metabolites Associated With Nondiabetic Chronic Kidney Disease: The HELIUS Study.
Journal: Kidney medicine
Published: July 04, 2025
Effects of dapagliflozin on sodium excretion, blood pressure and volume status in patients with type 2 diabetes and/or chronic kidney disease: The DAPASALT trial.
Journal: Diabetes, obesity & metabolism
Published: February 07, 2025
Mechanistic evaluation of ertugliflozin in patients with type 2 diabetes and heart failure.
Journal: Physiological reports
Published: January 15, 2025
The systemic and kidney hemodynamic response to empagliflozin, losartan and their combination varies between individuals.
Journal: Journal of nephrology
Published: December 24, 2024
Exposure-Response Analysis of the Sodium-Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes.
Journal: Journal of personalized medicine
Published: March 11, 2023
Mechanisms underlying the blood pressure-lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial.
Journal: Diabetes, obesity & metabolism
Published: June 04, 2022
Ethnic disparities in the association between low-grade inflammation biomarkers and chronic kidney disease: The HELIUS Cohort Study.
Journal: Journal of diabetes and its complications
Published: October 21, 2021
Last Updated: 09/26/2026